Laurie Toich, Assistant Editor

Top news of the day from across the healthcare landscape.

Large chunk of profits from prescription drug sales are going to supply chain entities and discounts.

Medicaid expansion did not address racial disparity among patients undergoing cancer surgery.

South Korea is moving to reform their health insurance program through a series of different steps.

Dietary resilience may reduce healthcare utilization among aging adults.

Without a special license, researchers can only conduct observational studies that include cannabis.

A cardiac lipid panel test plus a NT-proBNP test may be able to diagnose heart failure early.

A Pfizer company is recalling injectable Vancomycin Hydrochloride due to the presence of particulate matter.

Top news of the day from across the healthcare landscape.

Measures to standardize specialty pharmacy data should be put in place to improve the industry.

Patients with drug-eluting stents who used a tablet application had 10% higher medication possession ratio.

Governor Andrew M. Cuomo aims to provide access to women’s healthcare services that could be lost with a repeal of the Affordable Care Act.

Warfarin treatment plans change often, and paper forms may be inadequate.

The Opioid Safety Initiative reduced high- and very-high dose opioid prescriptions among veterans.

Increasing expression of hedgehog proteins may lead to speedier healing in patients with diabetes.

A high sensitivity cardiac troponin I test may determine if vorapaxar treatment would effectively prevent recurrent heart attacks.

Top news of the day from across the healthcare landscape.

An additional 6 months of market exclusivity would cover the costs of conducting new clinical trials.

The implementation of the Affordable Care Act increased the insured rate of patients with mental illness and substance use disorders.

Quest Diagnostics launches a test that determines patient response to costly hepatitis B virus drugs.

As outcomes-based contracting becomes more important, companies are aligning to promote the payment model.

Physical activity can help overcome comorbidities associated with aromatase inhibitor treatment for breast cancer.

Post-breast cancer treatment with aromatase inhibitors may cause adverse events.

A modifiable artificial heart allows researchers to study how gene mutations affect cardiac health.

Top news of the day from across the healthcare landscape.

A $450,000 research grant is targeting triple negative breast cancer and HER2-positive breast cancer.

Findings suggest that a majority of profits from prescription drug sales are going to supply chain entities and discounts.

Since the beginning of January, more than 63,000 individuals chose marketplace health plans.

Humira is currently approved to treat rheumatoid arthritis, inflammatory bowel disease, and psoriasis.

Changing warfarin management may prevent patients from receiving too much or too little of the drug.